Seller record · Telehealth service

eMI Aesthetics

By Paul Harris, Standards EditorRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 3 of 8 criteria. S4, compounding disclosure: The GLP-1 pages that sell compounded semaglutide and tirzepatide describe them as FDA-approved medications from trusted pharmacies, and the answer to whether the medications are FDA-approved says Wegovy and Ozempic are approved and compounded versions are made in FDA-regulated facilities. Only the telehealth consent says the FDA does not approve compounded products. 2 more criteria also fail; see the table below.

At a glance

eMI AestheticsTelehealth service

5/8criteria passed

Price: Compounded semaglutide from $179 a month, injection or oral; tirzepatide from $269
Sells: compounded semaglutide injection, compounded oral semaglutide, and 4 more
FDA letters: None on file

Visit eMI Aesthetics See all eight dispositions

Telehealth service. Passes 5 of 8 criteria. Recorded against Standard v1.1.

A platform of AI simulators for cosmetic and weight loss results that also sells a telehealth GLP-1 program of compounded semaglutide injections and tablets, tirzepatide and lower-dose plans, plus brand-name Ozempic and Zepbound, prescribed by independent licensed providers. Its terms name four partner pharmacies with street addresses.

Operating entity EntityMed Inc

Dispositions

Code	Criterion	Disposition	Where it appears
S1	Prescriber requirement	PASS	eMI Aesthetics' GLP-1 page; eMI Aesthetics' premium GLP-1 page
S2	Prescription gating	PASS	eMI Aesthetics' GLP-1 page; eMI Aesthetics' copy of legal page
S3	Pharmacy identification	PASS	eMI Aesthetics' copy of cancellation and refund policy
S4	Compounding disclosure	FAIL	eMI Aesthetics' GLP-1 page; eMI Aesthetics' premium GLP-1 page; eMI Aesthetics' copy of HIPAA page
S5	Analytical documentation	FAIL	eMI Aesthetics' GLP-1 page; eMI Aesthetics' GLP-1 medications page; eMI Aesthetics' copy of cancellation and refund policy
S6	Business address	FAIL	eMI Aesthetics' website; eMI Aesthetics' privacy policy; eMI Aesthetics' copy of HIPAA page
S7	Price disclosure	PASS	eMI Aesthetics' GLP-1 medications page; eMI Aesthetics' GLP-1 page
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSPrescriptions are issued by independent licensed providers after a telehealth consultation, and the steps say a provider prescribes only if medically appropriate after an online visit.Source: eMI Aesthetics' GLP-1 page; eMI Aesthetics' premium GLP-1 page.

S2PASSThe steps list a secure online form about health history first, then an online visit with a licensed provider for eligible patients, then a prescription if appropriate. The cancellation policy says membership begins and the first month is charged when the intake form is completed, with a full refund on medical disqualification.Source: eMI Aesthetics' GLP-1 page; eMI Aesthetics' copy of legal page.

S3PASSThe terms of use list four partner pharmacies with street addresses: RedRock Pharmacy, 1240 E 100 S #220, St. George, UT 84790; Health Warehouse, 7107 Industrial Rd., Florence, KY 41042; Precision Compounding Pharmacy, 2657 Merrick Road, Bellmore, NY 11710; and Triad Rx, 26258 Pollard Road, Daphne, AL 36526.Source: eMI Aesthetics' copy of cancellation and refund policy.

S4FAILThe GLP-1 pages that sell compounded semaglutide and tirzepatide describe them as FDA-approved medications from trusted pharmacies, and the answer to whether the medications are FDA-approved says Wegovy and Ozempic are approved and compounded versions are made in FDA-regulated facilities. Only the telehealth consent says the FDA does not approve compounded products.Source: eMI Aesthetics' GLP-1 page; eMI Aesthetics' premium GLP-1 page; eMI Aesthetics' copy of HIPAA page.

S5FAILNo certificate of analysis or lot document is published on the GLP-1 pages, the medications page or the terms of use.Source: eMI Aesthetics' GLP-1 page; eMI Aesthetics' GLP-1 medications page; eMI Aesthetics' copy of cancellation and refund policy.

S6FAILThe seller prints three different addresses. The footer gives a United States headquarters at 1065 SW 8th St #1768, Miami, FL 33130, the privacy policy gives 4 Hachoshlim St, Herzliya, Israel, and the telehealth consent sends privacy requests to 317 6th Ave. Ste. 400, Des Moines, IA 50309.Source: eMI Aesthetics' website; eMI Aesthetics' privacy policy; eMI Aesthetics' copy of HIPAA page.

S7PASSCompounded oral semaglutide and compounded semaglutide injection from $179 a month and tirzepatide injection from $269, with Zepbound from $1,399 and Ozempic from $1,299; the answers give plans from $179 a month. Plans of 4, 12, 24 and 52 weeks and lower-dose longevity plans are listed with no separate price.Source: eMI Aesthetics' GLP-1 medications page; eMI Aesthetics' GLP-1 page.

S8PASSNo FDA warning letter names eMI Aesthetics or EntityMed Inc, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded semaglutide injection, compounded oral semaglutide, tirzepatide injection, microdose semaglutide and tirzepatide plans, Ozempic, Zepbound.

Other sellers of the same products

Who sells semaglutide Who sells tirzepatide

Visit eMI Aesthetics

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.